Founded in 1993, The surgical Company, headquartered in The Netherlands, has gown both organically and through mergers and acquisitions to a group of 9 companies employing 350 employees and generating 140 million euro in annual sales. 9 companies are divided over 5 countries: Belgium, France, Germany, United Kingdom and The Netherlands.
Hemologic B.V. is a Dutch R&D company and a part of The Surgical Company (located in Amersfoort, The Netherlands). Hemologic B.V. aims to introduce a novel non-invasive cardiac diagnostic and monitoring technology, for use in the assessment of the hemodynamic function of the heart by measuring atrial and ventricular filling curves.
Drs. Charles Hollenkamp MD - Managing Director Hemologic, INSEAD MBA graduate, involved in the project since 2001 as an investor, also with a background in business consulting and an entrepreneur in healthcare, real estate and hospitality markets. Graduated as Medical doctor at the University of Amsterdam. Developed a number of private medical diagnostic centers (Meditel) in The Netherlands. Also serves as the medical affairs liaison to the project.
Principal members of the Hemologic project team
Dr. Henk Goovaerts - Biomedical and Electrical engineer consultant with a vast experience in development of haemodynamic measuring systems, involved since the inception of the company in 1993, has developed most of the electronic design and continues to contribute to the development of the associated electronics of the Hemodynamic Cardiac Profiler.
Dr. Maurits Konings - Clinical Physicist, University Medical Centre Utrecht, Project leader for the UMCU members working on the portable HCP. Invented the Field Recognition technique used in HCP and designed the mathematics and associated algorithm used for display of the filling curves.